Biomanufacturing’s Role in Building Resilient Pharma Supply Chains and Delivering Accessible Medicines

Pharmaceutical supply chains have evolved into a global ecosystem to optimize costs, volumes and capacities, and environmental regulations. However, there are still many vulnerabilities that make them unreliable, unpredictable, and unable to support the needs of a growing population.

Biomanufacturing offers an opportunity to fundamentally change how critical pharmaceutical ingredients are produced on a global scale, drive equitable access to essential medicines, and end drug shortages.

In this talk, Dr. Christina Smolke will discuss biomanufacturing’s critical role in transforming pharmaceutical supply chains and the key benefits of this innovative approach over legacy methods, including response time, scale, cost and agility.